Overview

ESGVS: Sclerotherapy With Lauromacrogol

Status:
Completed

Trial end date:
2006-12-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and the tolerance of echoguided sclerotherapy using Lauromacrogol 400 foam for the treatment of Great Saphenous Vein (GSV) insufficiency. A comparative study of 3% versus 1% Lauromacrogol 400 foam.

Phase:

Phase 3

Details

Lead Sponsor:

University Hospital, Grenoble

Treatments:

Polidocanol